EZH2 and colonic neoplasm: RNAi-mediated inhibition of EZH2 expression led to a significant reduction of cell numbers, which was clearly visible 48–72 hours following transfection of synthetic siRNAs (Figure 3A), indicating that EZH2 silencing results in growth inhibition of colon cancer cells.